Ultrasound Evaluation of Respiratory and Skeletal muscles in ILD
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2026
Project Lead
Authors
Dr. Shuvranu Ghosh, Dr. Uma Devraj, Dr. Priya, Dr. Uma Maheshwari, Dr. Kavitha. V, Dr. Chitra V, Dr. Deepa Susan John
Project Status
ongoing
Project Type
Non-Funded